Regulation of Pharmaceuticals & Medical Devices: Avanzado

Regulation of Pharmaceuticals & Medical Devices: Avanzado

Asuntos Regulatorios — Applied Drug + Device + Combination Product Strategy

Regulation of Pharmaceuticals & Dispositivos Médicos: Avanzado

Move from cross-categorical foundations to applied drug-plus-device regulatory work — applied ICH GCP planning, applied EU MDR / IVDR, applied combination-product analysis, applied adverse-event reporting, and a cross-categorical strategy memo.

RAQ-510-AAvanzado32 horasCertificado de Finalización

Solicita información y una cotización personalizada

Regulation of Pharmaceuticals & Dispositivos Médicos
FormatoCurso de Certificación Profesional
NivelAvanzado
Duración32 horas
IdiomaInglés
CertificadoCertificado de Finalización — Aleph University
Full course trackIntroductorio (16 h) + Avanzado (32 h) = 48 horas
Requisito previo / Preparación recomendada

Recommended prerequisite: completion of the Introductorio level for this training, or relevant professional experience subject to Aleph University review.

Descripción general

The Avanzado level of the Aleph Regulation of Pharmaceuticals & Dispositivos Médicos course track is for professionals who already know both regulatory worlds at orientation depth and need to develop the applied skills that cross-categorical RA work demands: planning a clinical investigation under ICH GCP and the applicable U.S. clinical-investigation regulations; applying the EU MDR and EU IVDR to a device submission and the EU centralised pharmaceutical procedure to a drug submission; analyzing a combination product under the FDA Office of Combination Products framework with Primary Mode of Action determination; conducting applied analysis on the MAUDE and FAERS adverse-event databases; and authoring a cross-categorical strategy memo that handles a real product spanning drugs and devices.

This 32-hour Curso de Certificación Profesional builds directly on the 16-hour Introductorio level (`RAQ-510-I`). It does not repeat the orientation material. Where the Introductorio level identifies IND and IDE, the Avanzado level constructs a clinical-investigation plan under each. Where the Introductorio level identifies MAUDE and FAERS, the Avanzado level conducts hands-on queries against both. The course culminates in a cross-categorical regulatory analysis course exercise — a portfolio-grade artifact in which the participant chooses a product (typically a combination product), constructs a parallel FDA and EMA strategy, and lays out the clinical-evidence plan that satisfies both jurisdictions.

Lo que aprenderás
Apply the FDA drug-development pathway (IND under 21 CFR Part 312; NDA under 21 CFR Part 314; BLA for biologics) to a real product scenario.
Apply the FDA device-development pathway (Controles de Diseño; 510(k); De Novo; PMA; IDE under 21 CFR Part 812) to a real product scenario.
Plan a clinical investigation under ICH E6(R3) Good Clinical Practice with the applicable U.S. regulations (21 CFR Parts 50, 56).
Apply EU MDR and EU IVDR to a device submission and the EU centralised pharmaceutical procedure to a drug submission.
Analyze a combination product under the FDA Office of Combination Products framework and determine the Primary Mode of Action.
Conduct applied analysis using the FDA MAUDE database (for devices) and FAERS (for pharmaceuticals), and meet the MedWatch reporting requirements.
Justify cross-jurisdictional regulatory pathway decisions with citations to primary sources.
Author a cross-categorical strategy memo for a chosen drug-and-device product as a portfolio-grade course artifact.
course topics & modules
Relevancia profesional

Graduates of the Avanzado course are positioned for applied work in cross-categorical Asuntos Regulatorios roles at integrated health-product manufacturers, at combination-product companies, at contract research organizations, in pharmacovigilance and post-market surveillance specialists, and at consultancies serving cross-categorical clients. The cross-categorical strategy memo produced during the course is a portfolio-grade artifact that demonstrates the participant’s ability to think strategically across drug and device worlds and across FDA and EU jurisdictions.

Certificado de Finalización

Los participantes que cumplan los requisitos de finalización del curso reciben un Certificado de Finalización emitido por Aleph University.

La finalización de los niveles Introductorio y Avanzado puede ser evaluada por Aleph University para su posible reconocimiento dentro de una ruta de posgrado aplicable, sujeto a revisión institucional y a las políticas académicas vigentes. El reconocimiento no es automático ni está garantizado.
Preguntas frecuentes
¿Listo para conversar sobre este curso?

Cuéntanos sobre tus objetivos, tu audiencia y tus plazos. Aleph University te contactará con información y una cotización personalizada para personas, equipos u organizaciones.

Disponible para participantes individuales y para formación en organizaciones.